Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124178873 | 12417887 | 3 | F | 201605 | 20160714 | 20160531 | 20160722 | EXP | JP-009507513-1605JPN012580 | MERCK | 26.00 | YR | F | Y | 85.00000 | KG | 20160722 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124178873 | 12417887 | 1 | PS | BELSOMRA | SUVOREXANT | 1 | Oral | 320 MG, UNK | 204569 | 320 | MG | TABLET | |||||||
| 124178873 | 12417887 | 2 | SS | BELSOMRA | SUVOREXANT | 1 | Oral | 20 MG, QD | 204569 | 20 | MG | TABLET | QD | ||||||
| 124178873 | 12417887 | 3 | SS | RESLIN TABLETS 25 | TRAZODONE HYDROCHLORIDE | 1 | Oral | 50 MG, DIVIDED DOSE FREQUENCY UNKNOWN | 0 | 50 | MG | TABLET | |||||||
| 124178873 | 12417887 | 4 | SS | RESLIN TABLETS 25 | TRAZODONE HYDROCHLORIDE | 1 | Oral | 25 MG, BID | 0 | 25 | MG | TABLET | BID | ||||||
| 124178873 | 12417887 | 5 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 96 MG, QD | 0 | 96 | MG | TABLET | QD | ||||||
| 124178873 | 12417887 | 6 | SS | ZOPICLONE | ZOPICLONE | 1 | Oral | 100 MG, QD | 0 | 100 | MG | TABLET | QD | ||||||
| 124178873 | 12417887 | 7 | SS | DEPAKENE | VALPROIC ACID | 1 | Oral | 11600 MG, QD, DIVIDED DOSE FREQUENCY UNKNOWN | 0 | TABLET | QD | ||||||||
| 124178873 | 12417887 | 8 | SS | JZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Oral | 400 MG, QD, DIVIDED DOSE FREQUENCY UNKNOWN | 0 | 400 | MG | TABLET | QD | ||||||
| 124178873 | 12417887 | 9 | SS | REFLEX | MIRTAZAPINE | 1 | Oral | 240 MG, QD, DIVIDED FREQUENCY DOSE UNKNOWN | 0 | 240 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124178873 | 12417887 | 1 | Insomnia |
| 124178873 | 12417887 | 2 | Suicide attempt |
| 124178873 | 12417887 | 3 | Suicide attempt |
| 124178873 | 12417887 | 5 | Suicide attempt |
| 124178873 | 12417887 | 6 | Suicide attempt |
| 124178873 | 12417887 | 7 | Suicide attempt |
| 124178873 | 12417887 | 8 | Suicide attempt |
| 124178873 | 12417887 | 9 | Suicide attempt |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124178873 | 12417887 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124178873 | 12417887 | Altered state of consciousness | |
| 124178873 | 12417887 | Asthenia | |
| 124178873 | 12417887 | Intentional overdose | |
| 124178873 | 12417887 | Suicide attempt | |
| 124178873 | 12417887 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124178873 | 12417887 | 1 | 20160523 | 20160523 | 0 | |
| 124178873 | 12417887 | 5 | 20160523 | 20160523 | 0 | |
| 124178873 | 12417887 | 6 | 20160523 | 20160523 | 0 | |
| 124178873 | 12417887 | 7 | 20160523 | 20160523 | 0 | |
| 124178873 | 12417887 | 8 | 20160523 | 20160523 | 0 |